Economics of myocardial perfusion imaging in Europe - The EMPIRE study

European Heart Journal

Volumn 20, Issue 2, 1999, Pages 157-166

  Underwood, S R ^a,d   Godman, B ^b   Salyani, S ^b   Ogle, J R ^e   Ell, P J ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Arthur D Little   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e NONE

Author keywords

Coronary artery disease; Cost effectiveness; Diagnosis; Economics; Myocardial perfusion scintigraphy

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FRANCE; GERMANY; HEALTH ECONOMICS; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; ITALY; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; UNITED KINGDOM;

EID: 0032935369     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1196     Document Type: Article

References (12)

1. Maddahi J. Myocardial perfusion imaging for the detection and evaluation of coronary artery disease. In: Skorton DJ, Schelbert HR, Wolf GL, Brundage BH, eds. Cardiac Imaging. A Companion to Braunwald's Heart Disease, 2nd Edn. Philadelphia: W. B. Saunders, 1996: 971-94.
2. Patterson RE, Eng C, Horowitz SF, Gorlin R, Goldstein SR. Bayesian comparison of cost-effectiveness of different clinical approaches to coronary artery disease. J Am Coll Cardiol 1984; 4: 278-89.
3. Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995; 91: 54-65.
4. Machecourt J, Reboud JP, Comet M, Wolf JE, Fagret D, Bourland P, Denis B. Cost: Efficacy ratio of diagnostic methods in coronary artery disease. Computer assisted Bayes' analysis: Value of exercise testing, radionuclide investigations and coronary angiography. Arch Mal Coeur Vaiss 1985; 78: 1769-78.
5. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982; 96: 102-9.
6. MIMS (Monthly Index of Medical Specialities). London: Haymarket Medical Ltd; 1996.
7. Pryor DB, Harrell Jr FE, Lee KL, Califf RM, Rosati RA. Estimating the likelihood of significant coronary artery disease. Am J Med 1983; 75: 771-80.
8. Berry DA. Statistics, A Bayesian Perspective. Belmont, CA: Duxbury Press; 1996.
9. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, McArthur D, Froelicher V. Exercise-induced ST depression in the diagnosis of coronary artery disease: A meta-analysis. Circulation 1989; 80: 87-98.
10. Marie PY, Danchin N, Durand JF, Feldmann L, Grentzinger A, Olivier P, Karcher G, Juilliere Y, Virion JM, Beurrier D et al. Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography: Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data. J Am Coll Cardiol 1995; 26: 879-86.
11. Pollock SG, Abbott RD, Boucher CA, Beller GA, Kaul S. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease: Validation of models based on these tests. Circulation 1992; 85: 237-48.
12. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 1991; 83: 363-81.